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Terpenoids are natural products known for their medicinal and commercial applications. 
Metabolic engineering of microbial hosts for the production of valuable compounds, such 
as artemisinin and Taxol, has gained vast interest in the last few decades. The Generally 
Regarded As Safe (GRAS) Bacillus subtilis 168 with its broad metabolic potential is 
considered one of these interesting microbial hosts. In the effort toward engineering B. 
subtilis as a cell factory for the production of the chemotherapeutic Taxol, we expressed 
the plant-derived taxadiene synthase (TXS) enzyme. TXS is responsible for the conversion 
of the precursor geranylgeranyl pyrophosphate (GGPP) to taxa-4,11-diene, which is the 
first committed intermediate in Taxol biosynthesis. Furthermore, overexpression of eight 
enzymes in the biosynthesis pathway was performed to increase the flux of the GGPP 
precursor. This was achieved by creating a synthetic operon harboring the B. subtilis 
genes encoding the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway (dxs, ispD, ispF, 
ispH, ispC, ispE, ispG) together with ispA (encoding geranyl and farnesyl pyrophosphate 
synthases) responsible for providing farnesyl pyrophosphate (FPP). In addition, a vector 
harboring the crtE gene (encoding geranylgeranyl pyrophosphate synthase, GGPPS, of 
Pantoea ananatis) to increase the supply of GGPP was introduced. The overexpression 
of the MEP pathway enzymes along with IspA and GGPPS caused an 83-fold increase 
in the amount of taxadiene produced compared to the strain only expressing TXS and 
relying on the innate pathway of B. subtilis. The total amount of taxadiene produced by 
that strain was 17.8 mg/l. This is the first account of the successful expression of taxadiene 
synthase in B. subtilis. We determined that the expression of GGPPS through the crtE 
gene is essential for the formation of sufficient precursor, GGPP, in B. subtilis as its innate 
metabolism is not efficient in producing it. Finally, the extracellular localization of taxadiene 
production by overexpressing the complete MEP pathway along with IspA and GGPPS 
presents the prospect for further engineering aiming for semisynthesis of Taxol.
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INTRODUCTION
Terpenoids represent the largest, structurally and functionally 
most varied group of natural products. This diversity is based 
on a structural complexity that cannot be  simply reproduced 
using chemical synthetic processes. Nowadays, there are over 
50,000 known terpenoids, a lot of which are biosynthesized by 
plants. Numerous terpenoids have attracted commercial interest 
for their medicinal value or use as flavors and fragrances. Among 
the most famous medicinally important terpenoids are the 
antimalarial artemisinin from the plant Artemisia annua and 
the anticancer paclitaxel (Taxol®) from the yew trees (Taxus 
brevifolia or Taxus baccata). The majority of terpenoids are 
naturally produced in low amounts and their extraction is usually 
labor intensive, and it entails considerable consumption of natural 
resources. For instance, the production of enough Taxol® to 
A
B
FIGURE 1 | (A) Biosynthesis of taxa-4,11-diene via the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway in Bacillus subtilis. Intermediates in the metabolic 
pathway: 1-deoxy-D-xylulose 5-phosphate (DXP), 2-C-methyl-D-erythritol 4-phosphate (MEP), 4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol (CDP-ME), 
2-phospho-4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol (CDP-MEP), 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MEC), (E)-4-hydroxy-3-methylbut-2-en-1-
yl diphosphate (HMBPP), isopentenyl diphosphate (IPP), dimethylallyl diphosphate (DMAPP), geranyl pyrophosphate (GPP), farnesyl pyrophosphate (FPP), and 
geranylgeranyl pyrophosphate (GGPP). Enzymes in the biosynthesis pathway: 1-deoxy-D-xylulose-5-phosphate synthase (Dxs), 1-deoxy-D-xylulose-5-
phosphate reductoisomerase, or 2-C-methyl-D-erythritol 4-phosphate synthase (Dxr, IspC), 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (IspD), 
4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol kinase (IspE), 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (IspF), (E)-4-hydroxy-3-methylbut-2-enyl-
diphosphate synthase (IspG), 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (IspH), isopentenyldiphosphate delta-isomerase (Idi), IspA which act as geranyl 
pyrophosphate synthase (GPPS) and farnesyl pyrophosphate synthase (FPPS), geranylgeranyl pyrophosphate synthase (GGPPS), and taxadiene synthase (TXS). 
(B) Plasmid constructs used for engineering B. subtilis. pDR_txs contains txs gene (red), preceded with B. subtilis mntA ribosomal binding site (dark red), to 
be inserted into the genome of B. subtilis between the amyE front flanking region and amyE back flanking region (purple), IPTG inducible hyperspank promoter 
(pink), and ampicillin and spectinomycin resistance cassettes (green). pBS0E_crtE contains crtE gene (yellow) encoding for GGPPS and preceded with B. subtilis 
mntA ribosomal binding site (dark red), xylose inducible promoter (orange), and ampicillin and erythromycin resistance cassettes (green). p04_SDFHCEGA contains 
seven genes of the MEP pathway, dxs, ispD, ispF, ispH, ispC, ispE, and ispG, along with the gene ispA (blue), each preceded with B. subtilis mntA ribosomal 
binding site (dark red), in a synthetic operon controlled by xylose inducible promoter (orange) and ampicillin and chloramphenicol resistance cassettes (green).
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treat one cancer patient would approximately require six 100-year-
old Pacific yew trees, and similarly, there are reports of enormous 
shortfalls in artemisinin production due to seed shortage. In 
addition, chemical synthesis and modification of most terpenoids 
is tremendously difficult and problematic because of the complexity 
and chirality of their chemical structures. Hence, researchers 
in the last few decades focused on metabolic engineering of 
the terpenoid biosynthetic pathways in host microorganisms as 
an alternate method of production (Connolly and Hill, 1991; 
Wagner et  al., 2000; Koehn and Carter, 2005; Julsing et  al., 
2006; Klein-Marcuschamer et  al., 2007).
The backbone of all terpenoids originates from 2 five-carbon 
precursors, isopentenyl diphosphate (IPP) and its isomer 
dimethylallyl diphosphate (DMAPP), which can be  produced 
via the mevalonate (MVA) pathway or the 2-C-methyl-D-
erythritol-4-phosphate (MEP) pathway. The consecutive 
condensation of IPP and DMAPP catalyzed by a group of 
prenyl pyrophosphate synthase enzymes produces the starting 
precursors of the different classes of terpenoids. These are (1) 
geranyl pyrophosphate (GPP; C10) produced by geranyl 
pyrophosphate synthase (GPPS) for the synthesis of 
monoterpenoids, (2) farnesyl pyrophosphate (FPP; C15) produced 
by farnesyl pyrophosphate synthase (FPPS) for the construction 
of sesquiterpenoids and triterpenoids, and (3) geranylgeranyl 
pyrophosphate (GGPP; C20) synthesized by geranylgeranyl 
pyrophosphate synthase (GGPPS) for the production of 
diterpenoids and tetraterpenoids. Finally, these starting precursors 
are cyclized and/or rearranged by terpene synthase enzymes 
to yield the different terpenoids (Withers and Keasling, 2007; 
Muntendam et  al., 2009; Abdallah and Quax, 2017).
Paclitaxel (Taxol®) is a diterpenoid known for its 
chemotherapeutic effect and is found in the bark and needles 
of different Taxus trees. Similar to all terpenoids, the extraction 
from the natural source is problematic, thus various Taxus species 
are now endangered due to high demand. Total synthesis of 
paclitaxel has been established, but the complexity of its chemical 
structure made the process commercially inapplicable (Nicolaou 
et  al., 1994). Hence, nowadays paclitaxel is synthesized 
semisynthetically from 10-deacetylbaccatin III that is more easily 
extracted from Taxus needles. Also, docetaxel, which has been 
gaining more attention recently due to its higher water solubility 
leading to improved pharmacokinetic properties and better potency, 
can be  synthesized from this precursor. However, this means 
that production still relies on the yew trees (Wuts, 1998; Baloglu 
and Kingston, 1999; Dewick, 2001). The first step in the production 
of paclitaxel is the production of the compound taxa-4,11-diene 
(Figure 1A). Taxadiene is produced from the cyclization of the 
diterpenoid precursor GGPP via the enzyme taxadiene synthase. 
The GGPP precursor can be  synthesized via the MVA and/or 
the MEP pathway as previously explained. Taxadiene is converted 
to the final product, paclitaxel, through approximately 19 enzymatic 
steps involving hydroxylation and other oxygenation reactions 
of the taxadiene skeleton (Hezari and Croteau, 1997; Julsing 
et  al., 2006; Abdallah and Quax, 2017).
The first committed intermediate in biosynthesis of 
paclitaxel, taxadiene, has been produced via metabolic 
engineering in Escherichia coli (Huang et al., 2001; Ajikumar 
et  al., 2010), Saccharomyces cerevisiae (DeJong et  al., 2006; 
Engels et  al., 2008), and the transgenic plant Arabidopsis 
thaliana (Besumbes et  al., 2004). Based on the success of 
taxadiene production in these hosts, Bacillus subtilis represents 
an interesting microbial host for the production of taxadiene 
where it has higher growth rate compared to S. cerevisiae 
and is mostly considered as GRAS (Generally Regarded As 
Safe) by the Food and Drug Administration unlike E. coli 
(Zhou et  al., 2013). Also, B. subtilis possesses an innate 
MEP pathway that can be  manipulated to increase the flux 
of precursors. An optimally regulated synthetic operon 
encompassing MEP pathway genes has been reported to 
lead to a high production of C30 carotenoids in B. subtilis 
(Xue et  al., 2015). Also, the sesquiterpenoid amorphadiene, 
which is the first precursor for the production of artemisinin, 
has been successfully produced in B. subtilis (Zhou et  al., 
2013). In the current study, we aim at the metabolic engineering 
of B. subtilis for the biosynthesis of taxadiene as a first step 
in the semisynthetic production of paclitaxel. For the first 
time, we  describe the successful expression of the enzyme 
taxadiene synthase essential for the synthesis of taxadiene 
in B. subtilis. Moreover, the production levels of taxadiene 
were increased by overexpression of the MEP pathway, IspA, 
and GGPPS enzymes. The reported B. subtilis strain with 
the highest level of production of taxadiene can strive to 
exceed yeast and E. coli, besides having the additional 
advantages provided from the use of B. subtilis. This study 
can serve as a stepping stone for further fine tuning of the 
biosynthetic pathway of paclitaxel in B. subtilis targeted at 
a sustainable and efficient production process.
MATERIALS AND METHODS
Bacterial Strains, Vectors,  
and Growth Conditions
Bacterial strains and expression vectors used in this research 
are listed in Table 1. E. coli DH5α strains were cultured in 
Luria-Bertani broth (LB), while B. subtilis 168 strains were 
grown in 2xYT medium. When necessary, growth media were 
supplemented with antibiotics in the following concentrations: 
100  μg/ml ampicillin or 100  μg/ml erythromycin for E. coli 
DH5α and 5  μg/ml chloramphenicol, 10  μg/ml erythromycin, 
or 10  μg/ml spectinomycin for B. subtilis 168.
Construction of Different Strains  
of B. subtilis 168
Three different constructs were utilized to produce different 
B. subtilis strains expressing taxadiene synthase (TXS). 
The first construct consists of txs gene from the plant 
Taxus baccata in pDR111 plasmid. The txs gene was 
truncated by deleting the first 60 amino acids to remove 
the signal peptide targeting the plastid in order to improve 
expression and solubility of the protein (Williams et  al., 
2000). Circular polymerase extension cloning (CPEC) 
(Quan and Tian, 2011) was used to create the pDR_txs construct 
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(Figure 1B) where B. subtilis mntA ribosomal binding site 
(RBS) plus spacer (AAGAGGAGGAGAAAT) were introduced 
before the txs gene along with a N-terminal 6× His-tag. 
Ampicillin and spectinomycin resistance cassettes are 
available for selection in E. coli and B. subtilis, respectively. 
The expression of TXS is controlled by IPTG inducible 
hyperspank promoter. The second construct consists of 
the crtE gene, encoding the GGPPS of Pantoea ananatis, 
together with the mntA RBS preceding the coding region. 
The gene was cloned into pBS0E plasmid containing xylose 
inducible promoter using CPEC method resulting in the 
construct pBS0E_crtE (Figure 1B). Finally, a construct 
expressing MEP pathway genes in pHCMC04G plasmid 
was used. The construct p04_SDFHCEGA (Figure 1B) 
expresses all the seven genes of the MEP pathway, dxs, 
ispD, ispF, ispH, ispC, ispE, and ispG, along with the 
gene ispA, each with its own engineered RBS, in one 
synthetic operon controlled by a xylose inducible promoter. 
p04_SDFHCEGA (16.4 Kb) was cloned using previously 
available constructs, p04_SDFH and p04_CEGA, by applying 
circular polymerase extension cloning (CPEC) (Quan and 
Tian, 2011; Xue et  al., 2015). All these cloning steps 
were performed in E. coli DH5α, and the sequences of all the 
generated recombinant plasmids were confirmed by sequencing 
(Macrogen, Europe). The constructed plasmids were used 
to transform competent B. subtilis 168 cells following 
previously published protocol (Kunst and Rapoport, 1995). 
Three different strains of B. subtilis 168 were produced 
by transforming different combinations of the constructs.
Expression of Taxadiene Synthase in  
B. subtilis 168
Overnight culture of the B. subtilis strain containing pDR_txs 
construct was grown in 2xYT medium containing 
spectinomycin antibiotic. The next day, the overnight culture 
was diluted to an OD600 of 0.07–0.1  in 10  ml 2xYT medium 
with spectinomycin in 100-ml Erlenmeyer flask. The culture 
was incubated for 3  h at 37°C and 220  rpm till OD600 of 
0.7–0.9. Then, IPTG was added to a final concentration of 
1  mM to start induction. The culture was divided into 1  ml 
cultures in 15  ml round bottom tubes and then grown 
overnight at 37, 30, or 20°C and 220  rpm. The following 
day, certain volumes of the cultures normalized to the 
OD600  =  1 were pelleted by centrifugation for 10  min at 
11,000  rpm, 4°C and then resuspended in Birnboim lysis 
buffer (25 mM Tris-HCl, pH 8.0, 50 mM glucose, cOmplete™ 
Protease Inhibitor Cocktail tablet from Sigma, and 25  mg/ml 
lysozyme) using an amount of 5  ml buffer per 1  g pellet 
and incubated at 37°C for 30  min. The soluble protein 
fractions were obtained by centrifugation for 15  min at 
11,000  rpm. The total protein concentration in each soluble 
protein fraction was estimated using NanoDrop® 
spectrophotometer. The samples from the expression 
experiment at different temperatures were loaded with the 
same total protein concentration on NuPAGE® gels (Invitrogen) 
for separation by SDS-PAGE and then analyzed by Western 
blotting where mouse peroxidase-conjugated anti-His antibody 
(catalog no. A7058; Sigma) was used followed by visualization 
using Amersham ECL Prime Western blotting detection 
reagent (catalog no. RPN2232; GE Healthcare).
Production and Extraction of Taxadiene in 
B. subtilis 168
All strains of B. subtilis 168 were grown with the suitable 
antibiotics using the abovementioned protocol for expression. 
In addition to IPTG, xylose was added at OD600 of 0.7–0.9 
to a final concentration of 1% to start induction of pBS0E 
and pHCMC04G constructs in txs  +  crtE and txs  +  crtE + 
SDFHCEGA B. subtilis strains. After which the cultures were 
divided into 1  ml cultures in 15  ml round bottom tubes and 
overlaid with 100  μl dodecane containing 10  μl of 700  μM 
β-caryophyllene as internal standard and then grown overnight 
(24 h) at 37, 30, or 20°C with 220 rpm shaking. The dodecane 
layer was added to trap the taxadiene released by the cells. 
The 24-h time point was chosen to ensure maximum production 
of taxadiene (Zhou et  al., 2013). The following day OD600 of 
all 1 ml cultures was measured. A comparison between taxadiene 
production at the different incubation temperatures along with 
the difference between direct extraction of taxadiene from 
the culture and extraction of taxadiene from cell lysate was 
performed. First, extraction without lysis was performed by 
adding 200  μl hexane to the 1  ml cultures overlaid with 
dodecane (1:3 dilution of dodecane), and then the cultures 
were centrifuged for 10  min at 11,000  rpm to separate the 
aqueous and organic phases. The dodecane-hexane layer was 
extracted for GC-MS analysis. Secondly, lysis followed by 
TABLE 1 | Bacterial strains and vectors used in this research.
Bacterial strain Genotype Reference
B. subtilis 168 trpC2 (Kunst et al., 1997;  
Barbe et al., 2009)
B. subtilis 168_txs 168 amyE::Phyperspank-txs; 
SpR
This study
E. coli DH5α F−endA1 hsdR17 (rk−,mk+) 
supE44 thi−1 λ−recA1 
gyrA96 relA1 
φ80dlacZ∆M15
Bethesda Research  
Lab 1986
Vector Pertinent properties Reference






pBS0E B. subtilis and E. coli 
shuttle vector; ori-1030 
(theta replication); copy 




pHCMC04G B. subtilis and E. coli 
shuttle vector; ori-pBS72 
(theta replication); copy 
number ~6; PxylA xylose-
inducible promoter; CmR; 
AmpR
(Xue et al., 2015)
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extraction was performed by addition of 100  μl lysis buffer 
(50  mM Tris-HCl, pH  8.0, 70  mM NaCl, 10  mM MgCl2, 
25 mg/ml lysozyme, and 0.1 mg/ml Dnase) to the 1 ml cultures 
overlaid with dodecane and incubation at 37°C for 30  min. 
Then, 200  μl 12% SDS (sodium dodecyl sulfate) was added. 
Finally, 200  μl hexane was mixed (1:3 dilution of dodecane), 
and the cultures were centrifuged for 10  min at 11,000  rpm. 
The dodecane-hexane layer was extracted for GC-MS analysis 
and comparison to the extract without lysis. All cultures and 
extractions were performed in triplicates.
Quantification of the Sampled Taxadiene
The dodecane-hexane samples were analyzed on an HP-5MS 
(5% Phenyl)-methylpolysiloxane column (Agilent J&W 0.25 mm 
inner diameter, 0.25 μm thickness, 30  m length) in a Shimadzu 
GCMS-QP5000 system equipped with a 17A gas chromatograph 
(GC) and AOC-20i autoinjector. The samples (2 μl) were injected 
splitless onto the GC column, and helium was used as the 
carrier gas. The injector temperature was 250°C, and the oven 
initial temperature was 100°C with an increase of 15°C per 
minute up to 130°C and then 5°C per minute till 210°C. After 
210°C was reached, the temperature was raised to 280°C with 
an increase of 35°C per minute and held for 2 min. The solvent 
cutoff was 8  min. The MS instrument was set to selected ion 
mode (SIM) for acquisition, monitoring m/z ion 122 for taxadiene 
and β-caryophyllene. The chromatographic peak areas for taxadiene 
and β-caryophyllene were determined using the integration tools 
in GCMSsolution 1.20 software (Shimadzu, Den Bosch, The 
Netherlands). A calibration curve of standard β-caryophyllene 
with concentration range of 0.5–28  mg/L was created based on 
chromatographic peak areas in SIM mode (m/z ion 122). For 
quantification of taxadiene, the peak area for each sample was 
corrected by using the peak corresponding to the internal standard 
β-caryophyllene (i.e., by multiplication of the taxadiene peak 
area for the sample by the peak area of reference β-caryophyllene, 
then division by the β-caryophyllene peak area of the sample). 
This correction is to avoid errors due to injection or loss during 
extraction. The taxadiene concentration in the diluted dodecane 
sample was calculated by applying the linear regression equation 
resulting from the calibration curve to each adjusted taxadiene 
peak area. Finally, the dilution factor was applied to calculate 
the concentration of taxadiene in the neat dodecane phase, and 
then this value was divided by 10 to determine the amount of 
taxadiene produced per liter of culture as the dodecane layer 
constitutes a second phase (10%) in the culture. The taxadiene 
concentration obtained for each sample was divided by the OD600 
of the corresponding culture to calculate the specific taxadiene 
production value (mg/L/OD600) β-caryophyllene equivalent 
(Rodriguez et  al., 2014).
Analysis of Segregational Stability of the 
Constructs in txs + crtE + SDFHCEGA  
B. subtilis Strain
Segregational stability was measured by evaluating the growth of 
B. subtilis 168 strain harboring the pDR_txs, pBS0E_crtE, and 
p04_SDFHCEGA constructs in 2xYT medium without antibiotics 
for 30 generations involving several subcultures by adapting a 
previously reported protocol (Shao et  al., 2015). The cells of B. 
subtilis 168 were first grown in 2 ml 2xYT broth containing 10 μg/
ml spectinomycin, 10  μg/ml erythromycin, and 5  μg/ml 
chloramphenicol to select the different constructs, respectively. The 
overnight cultures were inoculated into 2  ml fresh 2xYT broth 
without antibiotics and incubated at 37°C for 24  h, attaining full 
growth. The cultures were diluted 1:1,000 by fresh 2xYT broth 
without antibiotics and further incubated for 24  h where they 
were grown for the first 3  h at 37°C and then the temperature 
was reduced to 20°C to resemble the best conditions used for 
expression and production of taxadiene (growth of 1:1,000 dilution 
accounts for about 10 generations of cultivation, 210 = 1,024). These 
cultures were diluted 106 fold and plated onto 2xYT agar plates 
without antibiotics. Next day, 100 colonies were picked and transferred 
onto four different 2xYT agar plates supplemented with 10  μg/
ml spectinomycin, 10 μg/ml erythromycin, 5 μg/ml chloramphenicol, 
or a combination of the three antibiotics. This treatment was 
successively repeated three times to obtain 30 generations of 
cultivation. The presence of the constructs was confirmed by the 
growth of the colonies on the antibiotic plates corresponding to 
the antibiotic resistance gene in each plasmid, thus indicating that 
the plasmid hosted by the colonies is segregationally stable. The 
whole experiment from beginning to end was performed in duplicate. 
The segregational stability of each construct was represented as 
the average of the % of colonies retaining the plasmid construct, 
which is equal to [colonies on 2xYT plate with antibiotic/colonies 
on 2xYT plate without antibiotic * 100%].
Nucleotide Sequence Accession Number
The nucleotide sequence of the taxadiene synthase gene from 
the plant T. baccata was previously reported with the accession 
number: AY424738. The nucleotide sequence of the complete 
genome of P. ananatis was previously reported with the accession 
number: FUXY01000004. The crtE gene encoding the GGPPS 
enzyme was amplified from genomic DNA of P. ananatis, and 
the protein was assigned the accession number: SKA77365. 
The nucleotide sequence of the complete genome of B. subtilis 
168 was previously reported with the following accession 
numbers: AL009126 and NC000964. The MEP pathway genes 
used in this study were amplified from the genomic DNA of 
B. subtilis 168.
RESULTS
Construction of Different Strains of  
B. subtilis 168 Expressing Taxadiene 
Synthase
The first construct to be cloned was pDR_txs where the taxadiene 
synthase gene was cloned into pDR111 plasmid and then 
transformed into B. subtilis. This construct is designed to integrate 
the plant txs gene from T. baccata into the genome of B. subtilis 
where it is inserted into the amyE locus between the amyE front 
flanking region and amyE back flanking region (Overkamp et al., 
2013). The txs gene expresses the enzyme taxadiene synthase, 
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which is responsible for converting GGPP into taxa-4,11-diene. 
The expression of TXS from this construct is controlled by an 
engineered B. subtilis mntA ribosomal binding site and the strong 
IPTG inducible hyperspank promoter. The second construct 
produced was pBS0E_crtE, which is resulting from cloning the 
crtE gene from P. ananatis that encodes the GGPPS enzyme 
into pBS0E replicative plasmid. The GGPPS enzyme is responsible 
for the production of GGPP, which is the precursor of taxadiene. 
The pBS0E_crtE construct was transformed into B. subtilis strain 
containing pDR111_txs generating the txs  +  crtE strain. Finally, 
the construct overexpressing all genes of the MEP pathway along 
with ispA in one operon controlled by a xylose inducible promoter 
(p04_SDFHCEGA) was transformed into the txs  +  crtE strain 
generating the txs  +  crtE + SDFHCEGA B. subtilis strain. The 
aim was to increase the production of the precursors leading 
to the formation of taxadiene. All produced strains are listed in 
Table 2. The successful transformation of the constructs into 
the different B. subtilis strains was confirmed by colony PCR.
Expression of Taxadiene Synthase in  
B. subtilis 168
The taxadiene gene used is the natural gene from the plant 
T. baccata and was combined with the B. subtilis mntA RBS 
and a N-terminal 6× His-tag. pDR111 plasmid was chosen 
to integrate the txs gene into the genome of B. subtilis. The 
cell culture was lysed, and in the soluble protein fraction, 
the expression of TXS (approximately 89 kDa) has been clearly 
detected on Western blot by using specific antibodies against 
the His-tag as shown in Figure 2. Different growth temperatures 
(37, 30 and 20°C) were tried to determine the best temperature 
for the expression of TXS using the pDR_txs construct following 
induction by IPTG. Since the samples from expression at 
different temperatures were loaded with the same total protein 
concentration on SDS-PAGE gel, a comparison of the TXS 
band can determine the temperature resulting in the best 
expression. A clear band representing TXS was seen on Western 
blot (Figure 2) following expression at 20°C, while a very 
faint band was the result of expression at 30°C and no TXS 
band was visible after expression at 37°C. Hence, the temperature 
that showed best TXS expression upon induction was 20°C. 
This will later be  corroborated by the level of taxadiene 
production after incubation at the different temperatures.
Level of Production of Taxadiene in 
Different Strains of B. subtilis 168
The OD600 of the B. subtilis strains ranged from 7 to 9. The 
produced taxadiene was detected using GC-MS. The GC-MS 
chromatograms of the different B. subtilis strains showed the internal 
standard β-caryophyllene peak at retention time 9.25  min. and 
the taxadiene peak at retention time 20.05  min (Figure 3A). The 
SIM mode was used to monitor m/z ion 122 in the mass spectrum 
of both β-caryophyllene (Figure 3B) and taxadiene (Figure 3C). 
The peak areas were calculated and used to determine the 
concentration of produced taxadiene. The total amount of taxa-
4,11-diene (mg/L/OD600) produced in the B. subtilis strains at the 
different incubation temperatures was compared (Figure 4). The 
highest level of taxadiene production was observed after incubation 
at 20°C, which coincides with the best expression of TXS. After 
that, the effect of extraction of taxadiene with and without cell 
lysis was also compared in the different strains when incubated 
at 20°C (Figure 5). The txs strain, which only contains the pDR_txs 
construct, relies on the innate MEP pathway, IspA (acting as GPPS 
and FPPS), and GGPPS for the production of taxadiene in B. 
subtilis. It showed the lowest production of taxadiene (0.024 mg/L/
OD600) and was used as a control to compare the effect of 
overexpression of other genes on the production level. Introduction 
of crtE gene, encoding GGPPS enzyme, in the txs  +  crtE strain 
significantly increased the amount of taxadiene produced 
(0.471  mg/L/OD600), which is around 20 times higher than the 
control strain. This is probably due to the increased production 
TABLE 2 | Bacillus subtilis 168 strains generated in this study.
Strain Constructs Vectors Genes in the operon



















FIGURE 2 | Western blot of the soluble protein fraction showing taxadiene 
synthase expressed in Bacillus subtilis 168 after integration into the 
chromosome using pDR111 plasmid. The lanes show TXS bands (~89 kDa) 
resulting from expression at different temperatures as follows: 20, 30, and 
37°C. The enzyme was visualized by using specific antibodies against the 
His-tag.
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of the precursor GGPP. Finally, combining the txs  +  crtE strain 
with overexpression of the MEP pathway genes and the ispA gene 
showed much higher amounts of taxadiene with the strain expressing 
all the genes showing the highest production levels (1.981  mg/L/
OD600), which is approximately 83 times higher than the control 
strain. In addition, cell lysis before extraction did not show significant 
increase in the production levels compared to extraction without 
lysis (Figure 5). This indicates that taxadiene is released from the 
cells into the dodecane layer during growth. In fact, the omission 
of a cell lysis treatment resulted in a reduced contamination of 
the taxadiene due to the lysis buffer and SDS used. Actually, the 
non-lysed fermentation broth showed a thick cell pellet that could 
be removed easily by centrifugation, whereas the lysed broth showed 
a completely clear solution. Also, the chromatogram of the lysed 
culture showed extra peaks especially due to SDS. The addition 
of SDS was necessary for complete lysis, which could not be achieved 
with lysozyme alone. It is important to note that through following 
OD600 of the engineered strains compared to wild-type B. subtilis, 
it was clear that the engineered strains have slower growth rate 
especially at the best expression temperature which is 20°C. However, 
after the 24  h growth, both the engineered strains and wild type 
reached the same OD600.
Segregational Stability of the Constructs in 
txs + crtE + SDFHCEGA B. subtilis Strain
A bacterial strain is considered segregationally stable when 
all daughter cells get at least one plasmid during cell division. 
The development of plasmid-free cells can lead to a significant 
loss in productivity. The segregational stability of the pDR_txs, 
pBS0E_crtE, and p04_SDFHECEGA constructs in the txs + crtE 
+ SDFHCEGA B. subtilis strain was evaluated. The strain 
showed 100% ability to retain the pDR_txs and pBS0E_crtE 
constructs until the 30th generation along with 90% ability to 
retain the p04_SDFHECEGA construct (Figure 6) in the 
absence of antibiotics. Thus, this stability should be  sufficient 




FIGURE 3 | (A) GC chromatograms of the different strains of Bacillus subtilis in selected ion mode (SIM) for acquisition, monitoring m/z ion 122 to show the internal 
standard β-caryophyllene and the produced taxadiene peaks. (B) Mass spectrum of β-caryophyllene. (C) Mass spectrum of taxa-4,11-diene.
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DISCUSSION
In the past few decades, researchers focused on the use of 
metabolic engineering and synthetic biology to manipulate a 
variety of hosts for biosynthesis of numerous terpenoids. 
Biosynthetic pathways of terpenoids have been studied, and the 
majority of the genes involved have been identified (Barkovich 
and Liao, 2001; Kirby and Keasling, 2008; Niu et  al., 2017; 
Wang et al., 2017). Among these terpenoids is the chemotherapeutic 
paclitaxel. This study focused on the engineering of B. subtilis 
for the production of the first committed intermediate, taxa-
4,11-diene, in the biosynthesis of paclitaxel. The biosynthesis of 
taxadiene in B. subtilis (Figure 1A) proceeds via the MEP 
pathway to produce IPP and DMAPP that would eventually 
be  converted to the precursor GGPP. The enzyme taxadiene 
synthase cyclizes GGPP to produce taxa-4,11-diene (Croteau 
et  al., 2006). Hence, the expression of the enzyme taxadiene 
synthase in B. subtilis is a prerequisite for the production of 
taxadiene. Moreover, tuning of the MEP pathway in B. subtilis 
has been previously explored (Guan et  al., 2015; Xue et  al., 
2015) and can serve as a basis for improved production of 
taxadiene.
As a first step for the production of taxadiene in B. 
subtilis, the enzyme taxadiene synthase needs to be expressed. 
The gene encoding taxadiene synthase was amplified from 
the genome of the plant T. baccata that produces a protein 
of 862 amino acids. It has been reported that a pseudomature 
form of TXS where 60 amino acids were removed from 
the preprotein was superior in terms of level of expression, 
solubility, stability, and catalytic activity with kinetics 
analogous to that of the native enzyme (Williams et  al., 
2000). Hence, a truncated TXS protein eliminating the first 
60 amino acids (plastid targeting sequence) was expressed 
in B. subtilis. For successful expression in B. subtilis, the 
txs gene along with the B. subtilis mntA RBS and N-terminal 
6× His-tag was integrated into the chromosome using the 
pDR111 plasmid. The areas of the amyE gene flanking the 
txs gene in pDR111 allowed integration at the amyE locus 
in the B. subtilis chromosome. Following induction by IPTG 
at 20°C, a soluble TXS protein (~89  kDa) was expressed 
in B. subtilis and detected by Western blotting (Figure 2). 
The incubation at 20°C provided the best condition for 
expression of TXS as opposed to incubation at 30 or 37°C. 
The amount of taxadiene produced in this txs strain was 
very low, around 0.024  mg/L/OD600, indicating that further 
tuning of the pathway leading to the formation of the 
taxadiene precursor GGPP is essential to boost the taxadiene 
production level.
In pursuance of increasing the production of taxadiene, 
higher levels of the precursor GGPP is required. In the 
biosynthetic pathway (Figure 1A), IPP and DMAPP are 
converted to GPP with the enzyme GPPS, and then GPP 
is elongated to FPP using the enzyme FPPS, both encoded 
by the gene ispA. Finally, GGPPS enzyme produces GGPP 
from FPP. Studies on prenyl synthases of B. subtilis from 
the gene or protein perspective are still limited. B. subtilis 
is known for producing FPP, the precursor for sesquiterpenes, 
FIGURE 5 | Amount of taxa-4,11-diene (mg/L/OD600) β-caryophyllene 
equivalent produced by the different strains of Bacillus subtilis after incubation 
at 20°C. A comparison of the amounts produced by extraction of taxadiene 
with and without lysis of the cultures is presented. The experiment was 
performed in triplicates.
FIGURE 6 | Segregational stability of pDR_txs, pBS0E_crtE, and p04_
SDFHCEGA constructs in txs + crtE + SDFHCEGA Bacillus subtilis 168 strain. 
The stability is represented as the % of colonies retaining the plasmid constructs 
formed on the spectinomycin, erythromycin, or chloramphenicol-containing 
analytical plates, respectively, after successive subculturing in the absence of 
antibiotics (30 generations). The experiment was performed in duplicate.
FIGURE 4 | Amount of taxa-4,11-diene (mg/L/OD600) β-caryophyllene 
equivalent produced by the strains of Bacillus subtilis after incubation at 37, 
30, or 20°C. The extraction of taxadiene was carried out without lysis of the 
cultures. The experiment was performed in triplicates.
Abdallah et al. Engineering Bacillus subtilis for Taxadiene Biosynthesis 
Frontiers in Microbiology | www.frontiersin.org 9 February 2019 | Volume 10 | Article 218
and triterpenes, through its ispA encoded GPPS and FPPS 
(Kunst et  al., 1997; Kobayashi et  al., 2003; Julsing et  al., 
2007; Barbe et  al., 2009). The bacterium is also known to 
produce heptaprenyl (C35 terpenes) metabolites utilizing hepT 
and hepS encoding heterodimeric heptaprenyl diphosphate 
synthase enzymes that are responsible for producing 
heptaprenyl metabolite precursor from FPP (Zhang et  al., 
1998; Kontnik et  al., 2008). Up until now, albeit it was 
reported that B. subtilis possesses an enzyme capable of 
producing GGPP from experiments with a semipurified protein 
of B. subtilis long before the genome sequence of B. subtilis 
was revealed (Takahashi and Ogura, 1981, 1982), the definite 
annotation of the gene encoding GGPPS is still uncertain. 
The gene that encodes GGPPS can be found in microorganisms 
that produce C40 carotenoids, such as lycopene, where GGPP 
precursor is needed in their biosynthesis. Examples of these 
microorganisms are the Pantoea genus with its crtE gene 
and Corynebacterium glutamicum with its crtE and idsA genes 
(Hara et al., 2012; Heider et al., 2014; Walterson and Stavrinides, 
2015). CrtE of Pantoea has been widely used in metabolic 
engineering to produce high level of carotenoids and also 
C20 terpenoids in E. coli (Yoon et  al., 2007). Hence, the crtE 
gene from P. ananatis was cloned in the pBS0E vector and 
transformed into the B. subtilis txs strain. The amount of 
taxadiene produced (Figure 5) by the txs  +  crtE strain 
(0.471  mg/L/OD600) is approximately 20 times higher than 
the control txs strain (0.024  mg/L/OD600). This indicates that 
overexpression of the GGPPS enzyme is essential to increase 
the formation of GGPP precursor in B. subtilis and in turn 
improve the production level of taxadiene.
Finally, overexpression of the MEP pathway leads to 
increased production of IPP and DMAPP. The idi gene (the 
final gene in the MEP pathway encoding for an IPP isomerase) 
was not overexpressed by us due to previous indications 
that it is non-essential in B. subtilis (Takagi et  al., 2004). 
Past research also revealed that a knockout of the idi gene 
in B. subtilis is viable and produces isoprene, which implies 
that the synthesis of the isomer DMAPP does not rely on 
the isomerase (Eisenreich et  al., 2004; Julsing et  al., 2007). 
Note that, toxicity associated with the accumulation of prenyl 
diphosphates in B. subtilis with improved flux of MEP 
pathway has been reported (Sivy et  al., 2011). Hence, it 
was important to control the p04_SDFHCEGA construct 
with an inducible promoter. The B. subtilis strain expressing 
TXS, GGPPS, all the MEP pathway, and IspA (acting as 
GPPS and FPPS) enzymes proved that high supply of the 
GGPP precursor is essential. The txs  +  crtE + SDFHCEGA 
strain showed the highest level of production of taxadiene 
(1.981  mg/L/OD600), which is approximately 83 times higher 
than the txs control strain. The OD600 of this strain was 
approximately 9; hence, the total production of taxadiene 
is around 17.8  mg/L. This production level is higher than 
the amount reported in yeast 8.7  mg/L (Engels et  al., 2008) 
and in E. coli 11.3  mg/L (Bian et  al., 2017) on shake flask 
fermentation level. Also, the taxadiene production in B. 
subtilis is comparable to amorphadiene production that was 
previously reported in B. subtilis (Zhou et al., 2013). Moreover, 
our strain showed segregational stability of the different 
constructs up to the 30th generation of cultivation, which 
allow large-scale fermentations in the absence of antibiotics.
It is worth mentioning that the amount of taxadiene 
extracted from the cell culture with and without lysis is 
nearly the same (Figure 5). This indicates that taxadiene is 
released from the cells during growth and captured by the 
dodecane layer. It is also reported that the C15 amorphadiene 
produced in B. subtilis is trapped in the dodecane layer 
(Zhou et  al., 2013) as we  observed with our C20 taxadiene. 
Probably, due to their lipophilicity, they are able to permeate 
through the bacterial membrane and dissolve in the non-polar 
dodecane. However, C30 carotenoids are not exported from 
B. subtilis and have to be  isolated from the cell pellet after 
lysis (Yoshida et  al., 2009; Xue et  al., 2015). Also, C35 
heptaprenyl terpenes are produced in the spores of B. subtilis 
and not secreted (Bosak et  al., 2008). The fact that taxadiene 
is not trapped in the cells and that lysis is not necessary, 
makes large-scale production much simpler where the B. 
subtilis cell culture in fermenters can be overlaid with dodecane 
to collect the released taxadiene. In addition, contaminants 
from the lysis solution can be  avoided. As for E. coli, lysis 
is more likely to be  needed due to its double membrane 
compared to B. subtilis which has a single membrane.
In conclusion, the successful expression of the enzyme 
taxadiene synthase in B. subtilis is reported for the first time. 
The expression of GGPPS in B. subtilis is crucial for the sufficient 
production of the essential precursor GGPP. Hence, the production 
level of taxadiene is boosted by overexpression of GGPPS enzyme 
along with MEP pathway and IspA (acting as GPPS and FPPS) 
enzymes. This is a proof of concept that taxadiene can be efficiently 
produced in B. subtilis and can serve as the basis for engineering 
B. subtilis as a cell factory for paclitaxel production. The txs  +  crtE + 
SDFHCEGA strain can be  further engineered with additional 
enzymes (acyltransferases, cytochrome P450) necessary to produce 
10-deacetylbaccatin III, which can be  extracted and chemically 
converted to docetaxel or even paclitaxel (Walker and Croteau, 
2000). In the future, efforts to improve titer such as optimization 
of the growth medium and/or deletion of competing pathways 
in B. subtilis that divert the flux of FPP or GGPP can 
be explored with caution to ensure avoiding pathways essential 
for the survival of the bacteria (Julsing et  al., 2007; Guan 
et al., 2015; Zhao et al., 2016). Furthermore, process engineering 
to optimize pH, stirring, and aeration control will be required 
to develop the large-scale fed-batch fermentation system. 
Using the B. subtilis cell factory will eliminate the need to 
rely on the natural resources of the yew trees and thus 
avoid the endangering of the species and prevent shortfalls 
due to crop conditions.
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